Pacing and heart ablation for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a combination of heart pacing and a specialized ablation procedure in older adults with permanent atrial fibrillation that hasn't improved with other treatments. It aims to improve symptoms and reduce hospital stays related to heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have permanent atrial fibrillation (a continuous irregular heartbeat).
- You are 65 years or older.
- Standard medications or a prior ablation didn't work or caused side effects.
- You have symptoms like shortness of breath or fatigue with everyday activities (class II-IV).
- Your heart's pumping strength (LVEF) is above 40% on a recent test.
- You've been in the hospital for heart failure in the last year, or have high NT-proBNP levels recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat atrial fibrillation in people with heart failure where the heart's pumping strength is still normal. You'll either get a procedure called ablation to restore normal rhythm or medication to control your heart rate. The goal is to see which approach works better for people like you.
This study looks at how well a treatment called 'pace and ablate' works for people with atrial fibrillation. It involves using a pacemaker or similar device to control the heart rate, and it aims to see who benefits most and how they do over time.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This study investigates whether a catheter ablation procedure can improve wellbeing and reduce the risk of serious events for people 80 and older with symptomatic atrial fibrillation. The goal is to see if this treatment offers better outcomes than standard care in this age group.
This study compares two procedures for people who have both atrial fibrillation (AFib) and heart failure: one that slows the heart's electrical signals (AV node ablation) and one that helps the heart pump in a more coordinated way (cardiac resynchronization). Both are options when medications alone aren't enough, and the goal is to improve symptoms and quality of life.
This trial tests a special way to pace the heart and a procedure to quiet the irregular rhythm in people with advanced heart failure and long-standing atrial fibrillation. It may help improve symptoms and heart function, possibly reducing the need for a transplant.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.